BiotechTube
May Health

May Health

Paris, France· Est.
mayhealth.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

May Health is a clinical-stage medical device company pioneering a modern, interventional approach to treating infertility associated with Polycystic Ovary Syndrome (PCOS). The company's lead product, the Anavi System, is a CE Marked device that performs transvaginal ultrasound-guided ovarian ablation, a procedure intended to lower androgen production and restore ovulation in patients resistant to first-line oral medications. With its pivotal REBALANCE IDE trial currently enrolling in the U.S. to support an FDA submission, May Health is positioned to address a significant unmet need in a large, underserved patient population. The company is backed by prominent European life science investors including Sofinnova Partners and Trill Impact.

Women's HealthReproductive EndocrinologyInfertility

Technology Platform

Transvaginal ultrasound-guided ovarian ablation system (Anavi System) for targeted tissue destruction to lower androgen production and restore ovulation in PCOS.

Opportunities

The large, underserved population of PCOS patients resistant to first-line drugs represents a significant addressable market.
A successful one-time procedure could disrupt the current treatment pathway, offering a less invasive and potentially more cost-effective option before IVF, positioning May Health favorably in the growing fertility services market.

Risk Factors

The company faces high clinical and regulatory risk, as its entire value depends on the success of a single pivotal trial for FDA approval.
Post-approval, it must overcome commercialization challenges including physician training, insurance reimbursement, and competition from established pharmaceutical and IVF treatment paradigms.

Competitive Landscape

Competitors include pharmaceutical options (clomiphene, letrozole, gonadotropins), surgical laparoscopic ovarian drilling, and IVF services. May Health's Anavi procedure aims to compete as a minimally invasive, office-based second-line treatment, potentially carving out a unique niche between oral medications and more invasive/expensive options.

More companies in Regenerative Medicine →More companies in France →